DARYA BELYAYEVA: Open Payments
NPI 1265160683 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 12 payments from 11 companies in 2025. Trend: 2023 $704 · 2024 $940 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $245 |
| Averitas Pharma Inc. | 1 | $150 |
| Abbott Laboratories | 1 | $141 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| ABBVIE INC. | 1 | $99 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $88 |
Products named: Leqembi, QUTENZA, FREESTYLE LIBRE 3, RECORLEV, WAINUA, VRAYLAR, REXULTI, JOURNAVX.
Industry payments across VA — which companies pay providers there.
